DK165356C - Stabile frysetoerrede praeparater af et anticancer platinkompleks - Google Patents

Stabile frysetoerrede praeparater af et anticancer platinkompleks

Info

Publication number
DK165356C
DK165356C DK456886A DK456886A DK165356C DK 165356 C DK165356 C DK 165356C DK 456886 A DK456886 A DK 456886A DK 456886 A DK456886 A DK 456886A DK 165356 C DK165356 C DK 165356C
Authority
DK
Denmark
Prior art keywords
anticancer
freeze dried
dried preparations
stable freeze
platin
Prior art date
Application number
DK456886A
Other languages
Danish (da)
English (en)
Other versions
DK456886A (da
DK165356B (da
DK456886D0 (da
Inventor
Kazuhiro Shima
Takayuki Tsukada
Hirotane Kagawa
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK456886D0 publication Critical patent/DK456886D0/da
Publication of DK456886A publication Critical patent/DK456886A/da
Publication of DK165356B publication Critical patent/DK165356B/da
Application granted granted Critical
Publication of DK165356C publication Critical patent/DK165356C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK456886A 1985-09-25 1986-09-24 Stabile frysetoerrede praeparater af et anticancer platinkompleks DK165356C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60213180A JPH0665648B2 (ja) 1985-09-25 1985-09-25 白金系抗癌物質の安定な凍結真空乾燥製剤
JP21318085 1985-09-25

Publications (4)

Publication Number Publication Date
DK456886D0 DK456886D0 (da) 1986-09-24
DK456886A DK456886A (da) 1987-03-26
DK165356B DK165356B (da) 1992-11-16
DK165356C true DK165356C (da) 1993-04-05

Family

ID=16634867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK456886A DK165356C (da) 1985-09-25 1986-09-24 Stabile frysetoerrede praeparater af et anticancer platinkompleks

Country Status (9)

Country Link
US (1) US4767874A (de)
EP (1) EP0216362B1 (de)
JP (1) JPH0665648B2 (de)
KR (1) KR930010623B1 (de)
AU (1) AU593839B2 (de)
CA (1) CA1265745A (de)
DE (1) DE3669107D1 (de)
DK (1) DK165356C (de)
GB (1) GB2180839B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100877A (en) * 1986-05-21 1992-03-31 Kuraray Co., Ltd. Platinum containing pullulan derivatives and pharmaceutical compositions comprising the same
EP0307827A3 (de) * 1987-09-15 1989-12-27 Kuraray Co., Ltd. Makromolekulare Komplexe, ihre Herstellung und Verwendung in der Medizin
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
WO1990003402A1 (fr) * 1988-09-27 1990-04-05 Kuraray Co., Ltd. Nouveau compose, procede de preparation et son utilisation en medecine
DE3923270A1 (de) * 1989-07-14 1991-01-17 Medac Klinische Spezialpraep Wasserloesliche pharmazeutische metallocen-komplex-zusammensetzung
EP0516026A1 (de) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel und Verfahren zu seiner Herstellung
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
CA2457148A1 (en) * 2001-08-20 2003-02-27 Transave, Inc. Treatment of cancers by inhalation of stable platinum-containing formulations
CA2456746A1 (en) * 2001-08-20 2003-02-27 Transave, Inc. Method for treating lung cancers
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
CN1681478A (zh) * 2002-08-02 2005-10-12 川塞夫有限公司 铂聚集体及其制备方法
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
KR101301653B1 (ko) * 2002-10-29 2013-08-30 트랜세이브, 인코포레이티드 항감염제의 지속적인 방출
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
AU2005223654A1 (en) * 2004-03-18 2005-09-29 Transave, Inc. Administration of cisplatin by inhalation
US20060034906A1 (en) * 2004-05-21 2006-02-16 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
EP1811963A4 (de) * 2004-11-08 2010-01-06 Transave Inc Verfahren zur krebsbehandlung mit intraperitoneal verabreichten platinverbindungsformulierungen auf lipidbasis
US20060283742A1 (en) * 2005-06-16 2006-12-21 Canel Lightning Co. Ltd. Multi-lamp display packaging for lamps with collapsible lampshades
WO2007056236A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
WO2007056263A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007056264A2 (en) * 2005-11-08 2007-05-18 Transave, Inc. Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
WO2007064658A2 (en) * 2005-11-30 2007-06-07 Transave, Inc. Safe and effective methods of administering therapeutic agents
JP5324223B2 (ja) 2005-12-08 2013-10-23 トランセイブ, インク. 肺感染症を治療する抗感染薬の脂質ベースの組成物及びその使用法
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
PL2393476T3 (pl) * 2009-02-04 2016-07-29 Dsm Ip Assets Bv Kompozycje resweratrolu
CN101953805B (zh) * 2010-09-29 2012-05-30 贵州益佰制药股份有限公司 一种抗肿瘤药物制剂的制备方法
PL2852391T3 (pl) 2012-05-21 2022-04-11 Insmed Incorporated Układy do leczenia infekcji płuc
PL2892524T3 (pl) 2012-09-04 2021-10-25 Eleison Pharmaceuticals, Llc Zapobieganie nawrotom płucnym przy użyciu cisplatyny w kompleksie z lipidami
MX2015006681A (es) 2012-11-29 2016-04-06 Insmed Inc Formulaciones de vancomicina estabilizadas.
CN103315967B (zh) * 2013-06-18 2015-09-30 江苏奥赛康药业股份有限公司 一种含奈达铂的冻干组合物、用途及其制备方法
CN103599079B (zh) * 2013-11-25 2016-06-08 江苏奥赛康药业股份有限公司 注射用洛铂药物组合物及其制备方法
SMT202000516T1 (it) 2014-05-15 2020-11-10 Insmed Inc Metodi per trattamento di infezioni micobatteriche polmonati non tubercolari
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2019213398A1 (en) 2018-05-02 2019-11-07 Insmed Incorporated Methods for the manufacture of liposomal drug formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
JPS57123198A (en) * 1981-01-23 1982-07-31 Shionogi & Co Ltd Novel platinum complex
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4598091A (en) * 1983-02-18 1986-07-01 Degussa Aktiengesellschaft (1,2-diphenyl)-ethylenediamine)-platinum (II) complex compounds
JPS59222498A (ja) * 1983-06-01 1984-12-14 Shionogi & Co Ltd 新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
JPS617283A (ja) * 1984-06-20 1986-01-13 Shionogi & Co Ltd 新規白金錯体および抗悪性腫瘍剤
DE3582961D1 (de) * 1984-06-27 1991-07-04 Johnson Matthey Plc Platinkoordinationsverbindungen.
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
US4737589A (en) * 1985-08-27 1988-04-12 Nippon Kayaku Kabushiki Kaisha Platinum Complexes
HU196606B (en) * 1985-09-06 1988-12-28 Sankyo Co Process for producing antitumour platinum complexes and pharmaceutics comprising same

Also Published As

Publication number Publication date
JPH0665648B2 (ja) 1994-08-24
KR930010623B1 (ko) 1993-11-02
CA1265745A (en) 1990-02-13
GB2180839B (en) 1989-09-20
DK456886A (da) 1987-03-26
EP0216362A3 (en) 1987-07-29
DK165356B (da) 1992-11-16
GB2180839A (en) 1987-04-08
AU6310586A (en) 1987-03-26
KR870002846A (ko) 1987-04-13
US4767874A (en) 1988-08-30
DE3669107D1 (de) 1990-04-05
JPS6272615A (ja) 1987-04-03
DK456886D0 (da) 1986-09-24
EP0216362A2 (de) 1987-04-01
EP0216362B1 (de) 1990-02-28
GB8623117D0 (en) 1986-10-29
AU593839B2 (en) 1990-02-22

Similar Documents

Publication Publication Date Title
DK456886A (da) Stabile frysetoerrede praeparater af et anticancer platinkompleks
DK33287A (da) Imidazolanaloge af mevalonolacton og derivater deraf
DK148885D0 (da) Stabilt praeparat af interleukin-2
DK246886A (da) Vandig parenteral oplaesning af t-pa
DK528289A (da) Derivater af oploeseligt t-4
DK149988A (da) Stabile farmaceutiske praeparater
DK237187A (da) Farmaceutisk anvendelse af t-pa
DK56891D0 (da) Anvendelse af pesticidpraeparater
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK133786D0 (da) Praeparater
DK564886A (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
DK24986D0 (da) Praeparater
DK270988D0 (da) Nitrogenholdige derivater af epipodophyllotoxinglucosider
DK516286A (da) Fremgangsmaade til fremstilling af oxazolderivater
DK119588D0 (da) 27-halogen-derivater af ll-f28249-forbindelser
DK158224C (da) Fremgangsmaade til fremstilling af indolderivater
IT1214685B (it) Preparazioni di coloranti stabili
LV5506A3 (lv) Izoksazola atvasinajumu iegusanas panemiens
DK105089D0 (da) Fremstilling af bis(amin-holdige)benzendioler
DK466086D0 (da) Exogent syrnede antacidiumpraeparater
DK333587D0 (da) Anvendelse af pyridinderivater
BR8504188A (pt) Preparacao de terpinen-4-ois
DK326789D0 (da) Fremstilling af homonojirimycin-derivater
DK135387D0 (da) Fremstilling af proteiner
DK28386D0 (da) Fremstilling af peptider

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK